Skip to content

Christopher Michael Hidalgo

NPI 1710678206ActiveIndividual· Emergency Medicine· Lubbock, TX

Emergency Medicine in Lubbock, Texas, licensed in TX, with an NPI issued in May 2023. Part D covered 29 prescriptions written in 2024, 93% of them generic. Astrazeneca Pharmaceuticals LP reported $122.79 in payments in 2025, mostly food and beverage.

Overview

NPI1710678206
StatusActive
Entity typeIndividual
Sole proprietorYes
NPI issuedMay 16, 2023
Last updated in NPPESMar 24, 2025
Certified by providerMar 24, 2025

Specialties and licenses

TaxonomyCodeLicenseState
Emergency Medicine Primary207P00000XV6030TX

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Emergency Medicine (TX)

Part D prescriptions in 2024

Prescriptions (claims)29 · 36 30-day fills
Patients20
Total drug cost$253.11
Generic share93% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$122.79 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Astrazeneca Pharmaceuticals LP$122.791

What the 2025 payments were for

  • Food and Beverage$122.79 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other emergency medicine physicians in Lubbock

All 78 emergency medicine physicians in Lubbock · All emergency medicine physicians in Texas